Rebecca Gray
About
In The Last Decade
Rebecca Gray
36 papers receiving 911 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- General Health Professions 470
- Economics and Econometrics 290
- Epidemiology 200
- Surgery 110
- Pathology and Forensic Medicine 97
Countries citing papers authored by Rebecca Gray
This map shows the geographic impact of Rebecca Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Gray more than expected).
Fields of papers citing papers by Rebecca Gray
This network shows the impact of papers produced by Rebecca Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Gray. The network helps show where Rebecca Gray may publish in the future.
Co-authorship network of co-authors of Rebecca Gray
This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Gray. A scholar is included among the top collaborators of Rebecca Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Gray. Rebecca Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 6 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 69 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension | 1 |
| 17 | 10 | |
| 18 | 36 | |
| 19 | 53 | |
| 20 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.